SBP GROUP(01177),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01177 SBP GROUP

Trading 08-27 14:27:07

5.675

-0.060

-1.05%

High5.880	Low5.540	Vol46.57M
Open5.850	D1 Closing5.735	Amplitude5.93%
Mkt Cap106.03B	Tradable Cap106.03B	Total Shares18.68B
T/O262.51M	T/O Rate0.25%	Tradable Shares18.68B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"SBP GROUP","latestPrice":5.675,"timestamp":1787812016799,"preClose":5.735,"halted":0,"volume":46570158,"delay":0,"changeRate":-0.010462074978204096,"floatShares":18683000000,"shares":18683000000,"eps":0.15140605030416104,"marketStatus":"Trading","change":-0.06,"latestTime":"08-27 14:27:07","open":5.85,"high":5.88,"low":5.54,"amount":262514576,"amplitude":0.059285,"askPrice":5.675,"askSize":316000,"bidPrice":5.67,"bidSize":264000,"shortable":3,"etf":0,"ttmEps":0.15427555533692888,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787818200000},"marketStatusCode":2,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":5.735,"dividendRate":0.021556,"openAndCloseTimeList":[[1787794200000,1787803200000],[1787806800000,1787817600000]],"volumeRatio":0.36956,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.5032,"impliedVolPercentile":0.7469},"requestUrl":"/m/hq/s/01177","defaultTab":"news","newsList":[{"id":"1118314154","title":"Movement Alert｜SBP GROUP Falls 3.05% in Regular Trading, Trading at HK$5.545","url":"https://stock-news.laohu8.com/highlight/detail?id=1118314154","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118314154?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:20","pubTimestamp":1787797231,"startTime":"0","endTime":"0","summary":"On August 27, SBP GROUP fell 3.05% in regular trading, trading at HK$5.545/share, with Turnover of HK$102 million.Within the Pharmaceuticals sector where SBP GROUP belongs, individual stocks showed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151627337","title":"China's Innovative Weight-Loss Patch Receives US Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1151627337","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151627337?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:00","pubTimestamp":1787749241,"startTime":"0","endTime":"0","summary":"SBP GROUP has announced that its investigational drug CPX301, a dissolvable microneedle patch, has received a green light from the US Food and Drug Administration for clinical trials, with the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","IE00BZ08YS42.EUR","BK1521","BK1191","BK1515","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","HK0000165453.HKD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796495","title":"Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796495","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796495?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:32","pubTimestamp":1787733120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 2.1% to 5.74 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 37% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.2% and Amgen Inc. remained unchanged.Trading volume totaled 180.5 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK1191","IE00BJJMRZ35.SGD","HK0000165453.HKD","PJP","BK1589","BBH","IE00B2B36J28.USD","LU1023059063.AUD","BK4139","IBBQ","LU0122379950.USD","LU0289739699.SGD","BK4566","LU1983299246.USD","BK4588","LU2089984988.USD","SG9999001440.SGD","TBXU","PBE","BK4581","LU1057294990.SGD","LU0109394709.USD","IBB","BK1515","BIB","LU2242646821.SGD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK4585","LU0058720904.USD","IE00BZ08YR35.GBP","IE0002141913.USD","BK4534","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2112291526.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU0868494617.USD","BK1521","LU2242652126.USD","01177","BK4533","BK4599","LU1061106388.HKD","LU0889565916.HKD","LU1571399168.USD","IE0009355771.USD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179118608","title":"Movement Alert｜SBP GROUP Rises 3.29% in Regular Trading, GLP-1 Weight Management Microneedle Patch Receives US FDA Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1179118608","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179118608?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:47","pubTimestamp":1787708850,"startTime":"0","endTime":"0","summary":"On August 26, SBP GROUP rose 3.29% in regular trading, trading at 5.825 HKD/share, with turnover of approximately 190 million HKD.On the news front, the company announced that CPX301, a GLP-1...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SBP GROUP Rises on FDA Nod for GLP-1 Microneedle Patch","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662264783","title":"Sino Biopharma Wins FDA Clearance to Start Trial of Cpx301 GLP-1 Weight-Loss Microneedle Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662264783","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662264783?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:11","pubTimestamp":1787631069,"startTime":"0","endTime":"0","summary":"Sino Biopharma wins FDA clearance to start trial of CPX301 GLP-1 weight-loss microneedle patchSino Biopharmaceutical’s GLP-1 dissolving microneedle patch CPX301 received US FDA clearance to begin clin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL5FpTNh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","HK0000165453.HKD","01177","BK1515","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","BK1589","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273493","title":"Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.67 From HK$8.26, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273493","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273493?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:11","pubTimestamp":1787569902,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (HKG:1177) has an average rating of buy and mean price target of HK$8.48, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YT58.USD","BK1191","01177","BK1589","IE00BZ08YR35.GBP","BK1515","IE00BZ08YS42.EUR","BK1521","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661216000","title":"Sino Biopharmaceutical (SEHK:1177) Could Be 66% Below Fair Value As Earnings Lift Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2661216000","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661216000?lang=en_us&edition=fundamental","pubTime":"2026-08-22 16:18","pubTimestamp":1787386734,"startTime":"0","endTime":"0","summary":"Half year earnings update and why Sino Biopharmaceutical stock is in focus\nSino Biopharmaceutical (SEHK:1177) recently reported half year 2026 earnings, with sales of CNY 19,444.36 million and net income of CNY 3,434.6 million. Earnings per share from continuing operations also edged higher versus a year earlier.\nSee our latest analysis for Sino Biopharmaceutical.\nThe latest earnings release appears to have sharpened investor focus on Sino Biopharmaceutical, with the stock posting a 3.80% 1...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/sino-biopharmaceutical-sehk1177-could-be-66-below-fair-value","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/sino-biopharmaceutical-sehk1177-could-be-66-below-fair-value","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1589","PMDE","DECU","VOTE","BK1521","BK1515","FEBU","JOYT","BK1191","01177","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","HK0000165453.HKD","RGLO","DCF","IE00BZ08YT58.USD","GXDW","VGFPF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661901362","title":"Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2661901362","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661901362?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:15","pubTimestamp":1787346928,"startTime":"0","endTime":"0","summary":"Niki BioSolutionsweighs financing options as going-concern warning clouds post-merger outlookOverviewUS biopharmaceutical developer's H1 net loss widened, with loss per share at $1.6Operating expenses","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","BK1515","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1191","IE00BZ08YR35.GBP","BK4139","NIKI","IE00BZ08YT58.USD","BK1521","BK1574","02137","BK1583","BK1587","06996","BK1161","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163803683","title":"SBP Group's Novel Weight Management Therapy Gains Regulatory Nod for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1163803683","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163803683?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:38","pubTimestamp":1787308697,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) has announced that its subsidiary, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., has received approval from the Center for Drug Evaluation (CDE) of China's National Medical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","01177","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","IBBQ","BK1191","BK1521","BK1589","BMED","IE00BZ08YR35.GBP","MDTX","IBBJ","PSYK","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264881","title":"Sino Biopharm Says NMPA Clears Tqf6422 Obesity Drug Candidate for Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264881","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264881?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:17","pubTimestamp":1787307470,"startTime":"0","endTime":"0","summary":"Sino Biopharm says NMPA clears TQF6422 obesity drug candidate for clinical trialSino Biopharmaceutical unit Chia Tai Tianqing secured NMPA clearance to start clinical studies of TQF6422 obesity inject","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL71ZXMW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1589","BK1515","BK1521","01177","IE00BZ08YT58.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226102","title":"Sino Biopharmaceutical - Application for Clinical Trial on Tqf6422 Injection \"Actrii a/B Monoclonal Antibody\" Approved by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226102?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:17","pubTimestamp":1787307451,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44H1QX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","BK1589","BK1191","HK0000165453.HKD","BK1521","01177","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111305222","title":"Movement Alert｜SBP GROUP Rises 3.15% in Regular Trading, Continued Post-Earnings Momentum Supported by Analyst Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=1111305222","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111305222?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:29","pubTimestamp":1787279395,"startTime":"0","endTime":"0","summary":"On August 21, SBP GROUP rose 3.15% in regular trading, trading at HK$5.555/share with turnover of HK$226 million, extending gains following its blockbuster H1 results released on August 19.The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SBP Group Rises as Citi Lifts Target to HK$10.8","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661239225","title":"Sino Biopharmaceutical (SEHK:1177) Stock Faces Margin Strain Despite Profit Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2661239225","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661239225?lang=en_us&edition=fundamental","pubTime":"2026-08-21 01:40","pubTimestamp":1787247656,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical stock has been grinding higher in recent weeks, yet today’s reaction hangs almost entirely on one thing. The market is trying to make sense of a solid swing back to profit in H1 2026 while margin pressure refuses to ease.\nBasic earnings per share of C¥0.19 and net income of C¥3,434.60m mark a sharp contrast to the loss reported in H2 2025. At the same time, the latest net profit margin of 7.1% sits well below last year’s 12.8%. The question for you is whether today’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/sino-biopharmaceutical-sehk1177-stock-faces-margin-strain-de","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/sino-biopharmaceutical-sehk1177-stock-faces-margin-strain-de","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01177","IE00BZ08YT58.USD","BK1191","BK1521","BK1515","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","HK0000165453.HKD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660384532","title":"China's 3SBio H1 Net Profit Falls on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660384532","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660384532?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:37","pubTimestamp":1787236626,"startTime":"0","endTime":"0","summary":"China's 3SBio H1 net profit falls on higher expensesOverviewChina biopharmaceutical firm's half-year revenue rose 3.9% yr/yrNet profit attributable to shareholders fell 15.6% yr/yrGross profit increas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0M8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0069063385.USD","IE00BZ08YR35.GBP","BK1593","LU0124676726.USD","LU0689626769.HKD","IE00BZ08YT58.USD","BK1161","LU0472753341.HKD","LU2463526074.USD","IE00BZ08YS42.EUR","BK1191","BK1521","01530","01177","LU0203347892.USD","BK1589","LU0203345920.USD","LU0511384066.AUD","BK4585","IE000M9KFDE8.USD","LU0289961442.SGD","LU0057025933.USD","CMI","LU0154245673.USD","HK0000165453.HKD","LU0289739343.SGD","BK4149","BK4567","MADE","BK4588","BK1583","BK1515","BK4533","LU0154245756.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287767","title":"Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287767","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287767?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:40","pubTimestamp":1787233202,"startTime":"0","endTime":"0","summary":"Chinese medical device maker Zylox-Tonbridge's revenue rises 31%, aided by global expansionOverviewChina medical device maker's H1 revenue rose 31.1% yr/yr, driven by device sales growthNet profit for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYV24P56.USD","BK1574","BK1191","00867","00656","LU2488822045.USD","BK1583","HK0000165453.HKD","IE00BVYPNQ40.USD","BK1585","IE00BZ08YT58.USD","BK1593","BK1587","IE00BVYPNP33.GBP","BK1589","SG9999004220.SGD","BK1230","SG9999015978.USD","01696","SG9999015986.USD","01177","IE00BZ08YR35.GBP","BK1515","IE00BZ08YS42.EUR","BK1100","02190","SG9999015952.SGD","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","BK1521","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171384322","title":"Hong Kong Stocks Close Higher: Vaccine Sector Surges on Historic mRNA Cancer Trial Breakthrough, Gold Miners Rally Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1171384322","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171384322?lang=en_us&edition=fundamental","pubTime":"2026-08-20 17:03","pubTimestamp":1787216635,"startTime":"0","endTime":"0","summary":"Hong Kong's three major stock indexes closed higher on Tuesday, with the market buoyed by the successful Phase III clinical trial of the world's first mRNA cancer vaccine, which ignited the vaccine...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1769817179.HKD","159562","LU0431992006.USD","LU2097828631.EUR","01244","LU0164880469.USD","LU0348816934.USD","01177","LU0164865239.USD","LU0979878070.USD","02526","LU0588546209.SGD","HHImain","LU0348735423.USD","LU0345780281.USD","LU0096374516.USD","LU0572944931.SGD","LU0918141887.USD","LU0061477393.USD","BK1190","HSI","LU0266512127.USD","LU0348825331.USD","LU0307460666.USD","LU0456854461.SGD","LU0173614495.USD","LU0164939612.USD","LU0326950275.SGD","BK1543","LU1770034418.SGD","BK1191","BK1505","LU2008162690.USD","LU0048580855.USD","MHImain","BK1521","LU0043850808.USD","ARTY","LU0082770016.SGD","LU3063872942.SGD","LU1961090484.USD","LU1188198961.HKD","LU1251922891.USD","BK1589","HK0000252152.HKD","LU0828238088.HKD","07300","LU2097828557.USD","HK0000320223.HKD","LU2399975544.HKD","LU1303224171.USD","BK1161","03115","07200","BK1113","LU0348827113.USD","LU1808992512.USD","HK0000306701.USD","IE00BZ08YT58.USD","GLDW","LU0140636845.USD","LU1794554557.SGD","HK0000306685.HKD","HK0000252160.HKD","IE00BZ08YS42.EUR","03419","07500","LU0918141705.HKD","IE00BZ08YR35.GBP","LU0871576103.HKD","LU1282648689.USD","LU1224709979.USD","03037","LU0509642566.USD","LU0049853897.USD","LU0417516902.SGD","LU1242518931.SGD","BK4585","LU0269904917.USD","BK4588","LU2039709279.SGD","LU0469268626.HKD","HK0000320264.USD","VXUS","XLK","LU2264538146.SGD","BK1544","LU0329678170.USD","SG9999002463.SGD","82800","LU0328353924.USD","LU1105468828.SGD","MCHmain","LU0463099449.HKD","BK1515","LU1831875114.USD","LU0082770016.USD","02833","LU0106252389.USD","LU1064131342.USD","159646","BK1117","LU0039217434.USD","LU0106959298.USD","LU0211977185.USD","LU0244354667.USD","LU0634319403.HKD","LU1048596156.SGD","LU0828237510.HKD","LU0886674414.USD","02899","HSImain","LU1719994722.HKD","LU0149721374.USD","83115","BK1100","LU2097828474.EUR","LU0165289439.USD","LU0620787316.HKD","LU1242518857.USD","03983","LU0181495838.USD","02800","09115","LU0348814723.USD","LU0561508036.HKD","LU2177674079.SGD","LU2097828805.USD","LU0828237940.HKD","BK1592","LU1720050803.USD","LU0345780521.USD","LU0868486357.SGD","BK1198","LU0540923850.HKD","LU0417516738.SGD","LU1769817096.USD","BK1594","LU2226246903.HKD","LU0737861699.HKD","LU0737861772.HKD","IE0032431581.USD","LU1988902786.USD","LU0327786744.USD","02706","LU0821914370.USD","SG9999004220.SGD","LU1504937902.USD","LU0797268264.HKD","HK0000500386.USD","513600","LU0266512473.USD","LU0287142896.SGD","LU0370786039.SGD","KCAI","LU0228659784.USD","LU0329678337.USD","LU1481107354.HKD","LU2097828714.EUR","HK0000165453.HKD","LU0531971595.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402506","title":"Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402506?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:31","pubTimestamp":1787214660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. surged 13% to 5.39 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25698.49.The stock's rise snapped a two-day losing streak.Sino Biopharmaceutical Ltd. closed 41% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 9.6% and Amgen Inc. remained unchanged.Trading volume totaled 382.5 million shares, compared to the 50-day average of 95.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","HK0000165453.HKD","TBXU","BK4599","BBH","LU0109394709.USD","LU0889565916.HKD","LU1061106388.HKD","SG9999001440.SGD","BK1521","IBB","BK4534","IE00B4R5TH58.HKD","LU2242652126.USD","BK4533","IBBQ","IE00BZ08YT58.USD","BIB","BK4588","LU0320765992.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","AMGN","IE00BJT1NW94.SGD","BK1191","LU2468319806.SGD","LU0289739699.SGD","BK4581","LU1983299246.USD","IE00BZ08YR35.GBP","LU0122379950.USD","LU2242646821.SGD","01177","BK4585","PBE","LU2089984988.USD","BK1589","LU0868494617.USD","LU0058720904.USD","BK4139","IE00BFTCPJ56.SGD","LU2112291526.USD","BK4566","IE00B2B36J28.USD","LU1023059063.AUD","IE00BZ08YS42.EUR","LU1057294990.SGD","LU1571399168.USD","IE0009355771.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147356338","title":"Citi Lifts SBP GROUP Price Target to HK$10.8, Citing Strong H1 Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1147356338","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147356338?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:30","pubTimestamp":1787211022,"startTime":"0","endTime":"0","summary":"Citi has reiterated its \"Buy\" rating on SBP GROUP (01177), raising the target price from HK$10 to HK$10.8 following the company's better-than-expected first-half results.The pharmaceutical firm...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","BK4585","LU1144417596.USD","BK1191","LU0106831901.USD","LU1074936037.SGD","LU0980610538.SGD","LU2417539215.USD","IE00BZ08YR35.GBP","LU1244550577.SGD","LU0162691827.USD","LU2456880835.USD","IYF","LU2125154778.USD","LU0314106906.USD","LU2125154935.USD","LU0170899867.USD","LU1791807156.HKD","LU0310800965.SGD","LU0477156953.USD","LU1366192091.USD","EWH","FTXO","BK4207","LU0203345920.USD","BK4588","BK4566","LU0320765646.SGD","BK4559","IE00BSNM7G36.USD","LU2360032135.SGD","BK4534","IE00BZ08YS42.EUR","LU1244550494.USD","LU2236285917.USD","LU1244550221.USD","C","BK1521","LU1162221912.USD","LU0130102774.USD","LU0128525689.USD","LU0130517989.USD","BK4504","LU1506573853.SGD","BK1515","LU0648001328.SGD","BK1589","LU0072461881.USD","LU0098860793.USD","LU1201861249.SGD","01177","LU0052756011.USD","HK0000165453.HKD","IE00BZ08YT58.USD","LU0203347892.USD","LU1267930227.SGD","TFNS","LU1668664300.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660403108","title":"Finland's Nanoform Q2 Ebitda Loss Narrows on Layoffs, Cost Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403108","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403108?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:18","pubTimestamp":1787203114,"startTime":"0","endTime":"0","summary":"Finland's Nanoform Q2 EBITDA loss narrows on layoffs, cost cutsOverviewFinland medicine performance-enhancer's Q2 revenue grew 16% yr/yr, adjusted EPS loss narrowedCompany's Q2 EBITDA loss narrowed as","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H05H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","ONT.UK","BK1515","BK1589","BK1191","BK5062","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191961060","title":"Movement Alert｜SBP GROUP Rises 10.33% in Regular Trading, H1 Earnings Beat Expectations with Revenue Hitting Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1191961060","media":"Market Focus","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191961060?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:36","pubTimestamp":1787189791,"startTime":"0","endTime":"0","summary":"On August 20, SBP GROUP rose 10.33% in regular trading, trading at HK$5.4/share, with turnover of HK$182 million.The surge was driven by the company's interim results released on August 19, which...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SBP GROUP Rises as H1 Earnings Beat Expectations with Revenue Hitting Record High","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinobiopharm.com","stockEarnings":[{"period":"1week","weight":0.1973},{"period":"1month","weight":0.1267},{"period":"3month","weight":0.2058},{"period":"6month","weight":-0.0413},{"period":"1year","weight":-0.2966},{"period":"ytd","weight":-0.0614}],"compareEarnings":[{"period":"1week","weight":0.0062},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0259},{"period":"6month","weight":-0.0367},{"period":"1year","weight":0.005},{"period":"ytd","weight":0.0009}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly engaged in the long term investments business. The Others segment is mainly engaged in the related healthcare and hospital business.","yearOnYearQuotes":[{"month":1,"riseRate":0.434783,"avgChangeRate":0.007657},{"month":2,"riseRate":0.652174,"avgChangeRate":0.056403},{"month":3,"riseRate":0.565217,"avgChangeRate":0.046203},{"month":4,"riseRate":0.478261,"avgChangeRate":0.020807},{"month":5,"riseRate":0.695652,"avgChangeRate":0.037978},{"month":6,"riseRate":0.347826,"avgChangeRate":0.004739},{"month":7,"riseRate":0.652174,"avgChangeRate":0.052342},{"month":8,"riseRate":0.434783,"avgChangeRate":-0.004071},{"month":9,"riseRate":0.409091,"avgChangeRate":-0.014397},{"month":10,"riseRate":0.545455,"avgChangeRate":0.024699},{"month":11,"riseRate":0.5,"avgChangeRate":0.067223},{"month":12,"riseRate":0.409091,"avgChangeRate":-0.012172}],"exchange":"SEHK","name":"SBP GROUP","nameEN":"SBP GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SBP GROUP(01177),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SBP GROUP(01177) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SBP GROUP,01177,SBP GROUP股票,SBP GROUP股票老虎,SBP GROUP股票老虎国际,SBP GROUP行情,SBP GROUP股票行情,SBP GROUP股价,SBP GROUP股市,SBP GROUP股票价格,SBP GROUP股票交易,SBP GROUP股票购买,SBP GROUP股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SBP GROUP(01177),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SBP GROUP(01177) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}